Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update

For the three months ended September 30, 2025, Syndax reported a net loss attributable to common stockholders of $60.7 million, or $0.70 per share, compared to a net loss attributable to common ...

Pfizer Inc. (PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology Transcript

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...
C&EN

Measurement of Oro-Cecal Transit Time in LPS-Treated Pigs Fed High and Low Fiber Diets Using the Lactose-

Research Institute for Farm Animal Biology (FBN), 18196 Dummerstorf, Germany ...
GitHub

Test Explorer hangs (because it is stuck at the test collection stage) after the "Python" extension is updated to v2024.22.1

My "Python" extension has the Auto Update set, and today (Tue December 24, 2024) around 1:30pm (GMT+7), the auto update was kicked in to install v2024.22.1 on my Macbook (Sequoia 15.2 (24C101) ) and ...
ascopubs.org

Lorlatinib vs crizotinib in treatment-naïve patients with advanced ALK+ non-small cell lung cancer: 5-year progression-free survival and safety from the CROWN study.

Sacituzumab govitecan (SG) vs docetaxel (doc) in patients (pts) with metastatic non-small cell lung cancer (mNSCLC) previously treated with platinum (PT)-based chemotherapy (chemo) and ...